Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbcan.2013.08.001PMID 23933263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.

  2013cited by this paper
• Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis

  2013cited by this paper
• Oncogenes and angiogenesis: a way to personalize anti-angiogenic therapy?

  2013cited by this paper
• Tumor vasculature: the Achilles' heel of cancer?

  2013influential reference
• Microarray meta‐analysis defines global angiogenesis‐related gene expression signatures in human carcinomas

  2013cited by this paper
• Mechanisms of resistance to anti-angiogenesis therapies.

  2013cited by this paper
• Ovarian cancer stem cells: working towards the root of stemness.

  2013cited by this paper
• Cancer stem cells in the development of liver cancer.

  2013cited by this paper
• M2-Polarized Tumor-Associated Macrophage Infiltration of Regional Lymph Nodes Is Associated With Nodal Lymphangiogenesis and Occult Nodal Involvement in pN0 Pancreatic Cancer

  2013cited by this paper
• Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials

  2013cited by this paper
• Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.

  2013cited by this paper
• A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer.

  2013cited by this paper
• Update on bevacizumab and other angiogenesis inhibitors for brain cancer

  2013cited by this paper
• Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy.

  2013cited by this paper
• Nodal promotes invasive phenotypes via a Mitogen Activated Protein Kinase-dependent pathway

  2013cited by this paper
• Cancer stem cells and their role in metastasis.

  2013cited by this paper
• HIFs, angiogenesis, and cancer

  2013cited by this paper
• Regulation of Ovarian Cancer Stem Cells or Tumor-Initiating Cells

  2013cited by this paper
• Perivascular support of human hematopoietic stem/progenitor cells.

  2013cited by this paper
• Bevacizumab and advanced-stage ovarian cancer. Yet another oncological indication, but still best to avoid using this drug.

  2013cited by this paper
• Anti‐angiogenesis and metastasis: a tumour and stromal cell alliance

  2013influential reference
• Tumour endothelial cells acquire drug resistance in a tumour microenvironment.

  2013cited by this paper
• Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis.

  2013cited by this paper
• Radiotherapy targeting cancer stem cells: current views and future perspectives.

  2013cited by this paper
• Crosstalk between HER2 signaling and angiogenesis in breast cancer: molecular basis, clinical applications and challenges

  2013influential reference
• Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms.

  2013influential reference
• CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer

  2013cited by this paper
• c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α.

  2013cited by this paper
• Perivascular stem cell niche in head and neck cancer.

  2013cited by this paper
• A novel model for evaluating therapies targeting human tumor vasculature and human cancer stem-like cells.

  2013cited by this paper
• Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications.

  2013cited by this paper
• Mechanisms of chemoresistance in cancer stem cells

  2013cited by this paper
• Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis.

  2013cited by this paper
• Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity.

  2013influential reference
• Cancer stem cell contribution to glioblastoma invasiveness

  2013cited by this paper
• Vasculogenic mimicry and its clinical significance in medulloblastoma

  2012cited by this paper
• Intussusceptive Angiogenesis: A Biologically Relevant Form of Angiogenesis

  2012cited by this paper
• Angiogenesis inhibitors increase tumor stem cells

  2012cited by this paper
• Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors.

  2012cited by this paper
• Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cited by this paper
• Antiangiogenesis therapy in the treatment of metastatic colorectal cancer

  2012cited by this paper
• Significance of preoperative tissue levels of vascular-endothelial cadherin, liver-intestine cadherin and vascular endothelial growth factor in gastric cancer.

  2012cited by this paper
• Bevacizumab: overview of the literature

  2012influential reference
• Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

  2012cited by this paper
• Anti-angiogenesis therapy in cancer: current challenges and future perspectives.

  2012influential reference
• CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.

  2012cited by this paper
• Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cited by this paper
• Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature

  2012cited by this paper
• Cancer prevention by targeting angiogenesis

  2012cited by this paper
• Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.

  2012cited by this paper
• Zinc finger E‐box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial‐to‐mesenchymal transition

  2012influential reference
• Premetastatic niche: ready for new therapeutic interventions?

  2012cited by this paper
• Analysis of tumor‐induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus

  2012cited by this paper
• KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab

  2012cited by this paper
• Tumor microenvironment: a main actor in the metastasis process

  2012cited by this paper
• Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

  2012cited by this paper
• Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives

  2012cited by this paper
• Vasculogenic mimicry is a marker of poor prognosis in prostate cancer

  2012cited by this paper
• RETRACTED ARTICLE: Signaling pathways in tumor vasculogenic mimicry

  2012cited by this paper
• Human gastric cancer organizes neighboring lymphatic vessels via recruitment of bone marrow-derived lymphatic endothelial progenitor cells

  2012cited by this paper
• Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed.

  2012influential reference
• Bevacizumab in the Treatment of Ovarian Cancer

  2012cited by this paper
• Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial Progenitors

  2012cited by this paper
• Merkel cell carcinoma induces lymphatic microvessel formation.

  2012cited by this paper
• MET expression in melanoma correlates with a lymphangiogenic phenotype.

  2012cited by this paper
• Bevacizumab in the Treatment of Advanced Ovarian Cancer

  2012cited by this paper
• Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.

  2012cited by this paper
• Bevacizumab in non small cell lung cancer: development, current status and issues.

  2012cited by this paper
• Bevacizumab in advanced breast cancer: an opportunity as second-line therapy?

  2012cited by this paper
• Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets

  2012influential reference
• Building the niche: the role of the S100 proteins in metastatic growth.

  2012cited by this paper
• Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry

  2012cited by this paper
• Survival outcomes of bevacizumab beyond progression in metastatic colorectal cancer patients treated in US community oncology.

  2012cited by this paper
• Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts

  2012cited by this paper
• Role of the VEGF/VEGFR axis in cancer biology and therapy.

  2012cited by this paper
• Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.

  2012cited by this paper
• Anti-angiogenic drug discovery: lessons from the past and thoughts for the future

  2012cited by this paper
• Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator

  2012cited by this paper
• The origins of vacularization in tumors.

  2012cited by this paper
• Therapeutic targeting of VEGF in the treatment of glioblastoma

  2012cited by this paper
• Vasculogenic mimicry is a key prognostic factor for laryngeal squamous cell carcinoma: a new pattern of blood supply.

  2012cited by this paper
• Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes.

  2012cited by this paper
• Reappraisal of the role of bevacizumab in the therapeutic strategy in advanced renal cell carcinoma.

  2012influential reference
• Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis.

  2012cited by this paper
• The vascular niche: home for normal and malignant hematopoietic stem cells

  2012cited by this paper
• Tumor Blood Vessel “Normalization” Improves the Therapeutic Efficacy of Boron Neutron Capture Therapy (BNCT) in Experimental Oral Cancer

  2012cited by this paper
• Cancer stem cells and tumor angiogenesis.

  2012cited by this paper
• Interaction of tumor cells and lymphatic vessels in cancer progression

  2012influential reference
• HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma

  2012influential reference
• Antiangiogenic Therapy for Glioma

  2012cited by this paper
• Periodic acid Schiff loops and blood lakes associated with metastasis in cutaneous melanoma

  2012influential reference
• Anti-VEGF therapies in the clinic.

  2012influential reference
• Embryonic protein nodal promotes breast cancer vascularization.

  2012influential reference
• Ovarian Cancer: Advances in First-Line Treatment Strategies with a Particular Focus on Anti-Angiogenic Agents

  2012cited by this paper
• Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups

  2012cited by this paper
• Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.

  2012cited by this paper
• Antiangiogenic Therapy for Cancer: An Update

  2012cited by this paper
• Tumor-induced lymphangiogenesis in cervical lymph nodes in oral melanoma-bearing mice

  2012cited by this paper
• Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.

  2012cited by this paper
• Anti-VEGF/VEGFR therapy for cancer: reassessing the target.

  2012cited by this paper

• Drosophila melanogaster as a Model System for Human Glioblastoma.

  2025cites this paper
• Effect of Anatomical Site on Prognosis and Progression Pattern in Early-Stage Acral Melanoma: A Retrospective Cohort Study of 281 Cases.

  2025cites this paper
• Mapping of lymph node metastasis from esophageal squamous cell carcinoma after neoadjuvant treatment: a prospective analysis from a high-volume institution in China.

  2024cites this paper
• Selenium nanoparticles stabilized by Sargassum fusiforme polysaccharides: Synthesis, characterization and bioactivity.

  2024cites this paper
• Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial–Mesenchymal Transition and Angiogenesis

  2024cites this paper
• Compact Molecular Conformation of Prodrugs Enhances Photocleaving Performance for Tumor Vascular Growth Inhibition

  2024cites this paper
• Prognostic value of macrophage vasculiform mimicry in the evaluation of uveal melanoma progression

  2023cites this paper
• Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

  2023cites this paper
• Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche

  2022cites this paper
• ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer

  2022cites this paper
• A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer

  2022cites this paper
• The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.

  2022cites this paper
• Catulin reporter marks a heterogeneous population of invasive breast cancer cells with some demonstrating plasticity and participating in vascular mimicry

  2022cites this paper
• The role of tumor neogenesis pipelines in tumor progression and their therapeutic potential

  2022cites this paper
• Malaysian herbs as potential natural resources of anticancer drugs: From folklore to discovery

  2022cites this paper
• Hubungan antara Microvessel Density dan Lymphovascular Invasion dengan metastasis jauh pada pasien kanker payudara di RSUP Sanglah, Bali, Indonesia

  2021influential citation
• The Interplay between the Immune and the Endocannabinoid Systems in Cancer

  2021cites this paper
• Marine Bromophenol Bis(2,3,6-Tribromo-4,5-Dihydroxybenzyl)ether Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells and Reduces Vasculogenic Mimicry in Human Lung Cancer A549 Cells

  2021cites this paper
• Biologically active lipids in the regulation of lymphangiogenesis in disease states.

  2021cites this paper
• Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications.

  2021cites this paper
• Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages.

  2021cites this paper
• Tumor starvation by L-arginine deprivation

  2021cites this paper
• SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer

  2021cites this paper
• Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma

  2021cites this paper
• Anti-angiogenic therapy in ovarian cancer: current situation & prospects

  2021cites this paper
• Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

  2021cites this paper
• Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs

  2020cites this paper
• Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies

  2020cites this paper
• Antitumoral effects of fucoidan on bladder cancer

  2020cites this paper
• A Chinese Herbal Formula Suppresses Colorectal Cancer Migration and Vasculogenic Mimicry Through ROS/HIF-1α/MMP2 Pathway in Hypoxic Microenvironment

  2020cites this paper
• Label-free whole-colony imaging and metabolic analysis of metastatic pancreatic cancer by an autoregulating flexible optical system

  2020cites this paper
• Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors

  2020cites this paper
• Suppressive effects of Momordin Ic on HepG2 cell migration and invasion by regulating MMP-9 and adhesion molecules: Involvement of p38 and JNK pathways.

  2019cites this paper
• Cancer Stem Cells

  2019cites this paper
• Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.

  2019cites this paper
• Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors

  2019cites this paper
• Histological study on freund's complete adjuvant induced arthritis in rat models following treatment with crude Egyptian scorpion venom and methotrexate

  2019cites this paper
• Potential Anti-Inflammatory Effects of the Egyptian Scorpion (Androctonus amoreuxi) Venom in Rheumatoid Rat Model

  2019cites this paper
• Tea and Its Components Prevent Cancer: A Review of the Redox-Related Mechanism

  2019cites this paper
• Gynecologic Malignancies

  2019cites this paper
• BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells.

  2019cites this paper
• Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies—A review

  2018cites this paper
• Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers

  2018cites this paper
• FUNCTIONALIZATION OF POROUS SILICON NANOVECTORS FOR TARGETED CANCER THERAPY

  2018cites this paper
• Triptonide potently suppresses pancreatic cancer cell‐mediated vasculogenic mimicry by inhibiting expression of VE‐cadherin and chemokine ligand 2 genes

  2018cites this paper
• Three‐Dimensional Osteosarcoma Models for Advancing Drug Discovery and Development

  2018cites this paper
• Expression of vimentin and CD44 in mucoepidermoid carcinoma: A role in tumor growth

  2018cites this paper
• Chronic resveratrol treatment reduces the pro-angiogenic effect of human fibroblast "Senescent Associated Secretory Phenotype" (SASP) on endothelial colony forming cells: the role of IL8.

  2018cites this paper
• Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling

  2018cites this paper
• High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells

  2018cites this paper
• The role of sema4D in vasculogenic mimicry formation in non‐small cell lung cancer and the underlying mechanisms

  2018cites this paper
• Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer

  2018cites this paper
• The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma

  2018cites this paper
• Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in MCF 10 A Cells via ERK 2 June

  2017cites this paper
• Evaluation on biological compatibility of carboxymethyl chitosan as biomaterials for antitumor drug delivery

  2017cites this paper
• Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib

  2017cites this paper
• Paclitaxel-induced hypothermia and hypoperfusion increase breast cancer metastasis and angiogenesis in mice

  2017cites this paper
• Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.

  2017cites this paper
• Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy

  2017cites this paper
• Sphingosylphosphorylcholine Induces Thrombospondin-1 Secretion in MCF10A Cells via ERK2

  2017cites this paper
• Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.

  2017cites this paper
• MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression.

  2017cites this paper
• Development of an endothelial-like cell line from the brain of the American eel and its use to study the effects of selenium

  2017cites this paper
• RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro

  2017cites this paper
• Resistance to Tyrosine Kinase Inhibitors in Different Types of Solid Cancer

  2016cites this paper
• Protéine-kinases et cancer du rein : Découverte et validation d’une nouvelle combinaison d’inhibiteurs ciblant les protéine-kinases ATM et CK2

  2016cites this paper
• Angiogenesis in Liver Cancer

  2016cites this paper
• In Vitro Assays for Endothelial Cell Functions Required for Angiogenesis: Proliferation, Motility, Tubular Differentiation, and Matrix Proteolysis.

  2016cites this paper
• miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.

  2016cites this paper
• Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma.

  2016cites this paper
• Development of a cell line from the American eel brain expressing endothelial cell properties

  2016cites this paper
• Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation

  2016cites this paper
• The role of lymphangiogenesis and angiogenesis in tumor metastasis

  2016cites this paper
• Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer

  2016cites this paper
• Role of Redox Status in Development of Glioblastoma

  2016cites this paper
• Arginine dependence of tumor cells: targeting a chink in cancer’s armor

  2016cites this paper
• Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance

  2016cites this paper
• β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase

  2016cites this paper
• Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells

  2016cites this paper
• Lymphatic vessels: an emerging actor in atherosclerotic plaque development

  2015cites this paper
• Dehydroeffusol effectively inhibits human gastric cancer cell-mediated vasculogenic mimicry with low toxicity.

  2015cites this paper
• Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities

  2015cites this paper
• All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation

  2015cites this paper
• The importance of the tumor microenvironment in the therapeutic management of cancer

  2015cites this paper
• The evolving role of the endocannabinoid system in gynaecological cancer.

  2015cites this paper
• Imidazole‐based alkaloid derivative LCB54‐0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization

  2015cites this paper
• Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment.

  2015cites this paper
• Hypercoagulation in colorectal cancer: What can platelet indices tell us?

  2015cites this paper
• Urothelial bladder cancer progression: lessons learned from the bench

  2015cites this paper
• The redox biology network in cancer pathophysiology and therapeutics

  2015cites this paper
• Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells

  2015cites this paper
• MMP13 Regulates Aggressiveness of Pediatric Multiple Myeloma Through VEGF-C

  2015cites this paper
• Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.

  2015cites this paper
• Stem Cells Therapy

  2014cites this paper
• Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms.

  2014cites this paper
• Cannabinoids as therapeutic agents in cancer: current status and future implications

  2014cites this paper
• Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

  2014cites this paper
• Anti-Metastasis Effect of Fucoidan from Undaria pinnatifida Sporophylls in Mouse Hepatocarcinoma Hca-F Cells

  2014cites this paper
• Looking back, to the future of circulating tumor cells.

  2014cites this paper
• Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in 
Clear - Cell Renal Cell Carcinoma (ccRCC)

  2013cites this paper